Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. It...
Bone Biologics raises $3 million in private placement
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants
Bone Biologics shares are trading lower after the company announced a private placement of 2.1 million shares and warrants at $1.42 per unit.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket